NEW YORK (GenomeWeb News) – EMD Millipore said today that its Discovery and Development Solutions business has received CLIA certification for its contract research lab located in St. Louis.

The Billerica, Mass.-based division of Germany's Merck KGaA said that the Discovery and Development Solutions business develops and performs immunoassays on human and animal samples and offers biomarker analysis for an array of therapeutic applications including diabetes, infection, neurodegenerative disease, osteoporosis, and cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.